Date published: 2026-6-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SI-CLP Antibodies

Santa Cruz Biotechnology features a diverse variety of SI-CLP monoclonal antibodies for advanced research in cellular and molecular biology. SI-CLP monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SI-CLP, or Signal-Induced Cell Lymphocyte Protein, plays a crucial role in immune response regulation and cell signaling pathways. Understanding SI-CLP function is essential for revealing mechanisms of immune system activation and modulation, which can have significant implications in immunology and therapeutic development. SI-CLP research is particularly relevant in studying autoimmune diseases and cancer, where expression and activity can influence disease progression and treatment outcomes. Researchers worldwide rely on SI-CLP monoclonal antibodies to explore cellular mechanisms and pathways involved in immune system regulation. Advanced research techniques supported by SI-CLP monoclonal antibodies enable detailed analysis of protein expression, localization, and interactions. Santa Cruz Biotechnology monoclonal antibodies for SI-CLP research continue to support scientific discoveries that advance our understanding of immune system function and disease treatment.

SEE ALSO...

SI-CLP Antibodies

Empty Table HeaderProduct NameCATALOG #ISOTYPEEPITOPEAPPLICATIONSSpeciesCitationsRATING

SI-CLP Antibody (A-1)

sc-514286mouse IgG1 κ37-51 (h)WB, IP, IF, ELISAm, r, h
1
(2)

SI-CLP siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers

Empty Table HeaderProduct NameCATALOG #SpeciesAPPLICATIONSMARKERCitationsRATING

SI-CLP siRNA (h)

sc-96646hGene SilencingN/A0
(0)

SI-CLP shRNA Plasmid (h)

sc-96646-SHhGene SilencingPuromycin0
(0)

SI-CLP shRNA (h) Lentiviral Particles

sc-96646-VhGene SilencingPuromycin0
(0)